Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infectionNina Hensel, Maike Hofmann, Zuguang Gu et al.|Nature Immunology|2021Cited by 162
TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infectionKathrin Heim, Robert Thimme, Benedikt Binder et al.|Gut|2020Cited by 80
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1–3 InfectionsJulia Dietz, F. Kocheise, Kai‐Henrik Peiffer et al.|Clinical Gastroenterology and Hepatology|2019Cited by 13
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJulia Dietz, R. Zachoval, Christiana Graf et al.|JHEP Reports|2024Cited by 8
Robust HLA-B-restricted CD8+ T-cell responses in chronic HBV infectionJulia Lang‐Meli, Christoph Neumann‐Haefelin, Anna-Lena Denecke et al.|JHEP Reports|2026Cited by 0